AstraZeneca Results Presentation Deck

In memory of José Baselga (1959-2021) 31 30M Ⓡ ● José Baselga tragically passed away on 21 March 2021 José joined AstraZeneca in early 2019 as Executive Vice President and Head of Oncology R&D, but had been supporting AstraZeneca in various advisory capacities for a number of years José has left a lasting legacy on AstraZeneca, including: Collaborations on Enhertu and datopotamab deruxtecan ● Ⓡ Strategy for breast cancer and other cancer areas Extensive use of novel biomarkers in development A number of other key initiatives Relentless focus on patients and their care B

View entire presentation